HBIO Harvard Bioscience Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: HBIO

Price (delayed)

$3.97

Market cap

$172.3M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.08

Enterprise value

$210.79M

Harvard Bioscience is a leading developer, manufacturer and seller of technologies, products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its customers range from renowned ...

Highlights
The EPS has soared by 65% YoY
Harvard Bioscience's debt has decreased by 21% YoY and by 6% from the previous quarter
The company's net income has surged by 64% YoY but it fell by 4.7% QoQ
HBIO's quick ratio is down by 15% YoY and by 8% QoQ
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: http://www.harvardbioscience.com
Peers: BRKR A TMO JNJ

Key stats

What are the main financial stats of HBIO
Market
Shares outstanding
43.4M
Market cap
$172.3M
Enterprise value
$210.79M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.32
Price to sales (P/S)
1.5
EV/EBIT
203.66
EV/EBITDA
26.24
EV/Sales
1.88
Earnings
Revenue
$112.25M
EBIT
$1.04M
EBITDA
$8.03M
Free cash flow
$11.72M
Per share
EPS
-$0.08
Free cash flow per share
$0.28
Book value per share
$1.71
Revenue per share
$2.65
TBVPS
$1.51
Balance sheet
Total assets
$137.37M
Total liabilities
$64.29M
Debt
$42.77M
Equity
$73.07M
Working capital
$22.5M
Liquidity
Debt to equity
0.59
Current ratio
1.85
Quick ratio
0.77
Net debt/EBITDA
4.79
Margins
EBITDA margin
7.2%
Gross margin
58.9%
Net margin
-3%
Operating margin
1.7%
Efficiency
Return on assets
-2.4%
Return on equity
-4.6%
Return on invested capital
1.2%
Return on capital employed
0.9%
Return on sales
0.9%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

HBIO stock price

How has the Harvard Bioscience stock price performed over time
Intraday
-2.93%
1 week
-8.63%
1 month
-4.34%
1 year
-16.24%
YTD
-25.79%
QTD
-6.37%

Financial performance

How have Harvard Bioscience's revenue and profit performed over time
Revenue
$112.25M
Gross profit
$66.07M
Operating income
$1.89M
Net income
-$3.42M
Gross margin
58.9%
Net margin
-3%
Harvard Bioscience's operating margin has soared by 128% YoY and by 70% from the previous quarter
HBIO's operating income has surged by 127% year-on-year and by 64% since the previous quarter
The company's net income has surged by 64% YoY but it fell by 4.7% QoQ
Harvard Bioscience's net margin has soared by 64% YoY but it has decreased by 3.4% from the previous quarter

Growth

What is Harvard Bioscience's growth rate over time

Valuation

What is Harvard Bioscience stock price valuation
P/E
N/A
P/B
2.32
P/S
1.5
EV/EBIT
203.66
EV/EBITDA
26.24
EV/Sales
1.88
The EPS has soared by 65% YoY
HBIO's price to book (P/B) is 17% less than its last 4 quarters average of 2.8
The stock's price to sales (P/S) is 17% less than its last 4 quarters average of 1.8 and 6% less than its 5-year quarterly average of 1.6

Efficiency

How efficient is Harvard Bioscience business performance
HBIO's return on invested capital has surged by 118% year-on-year but it is down by 20% since the previous quarter
The ROS has soared by 115% YoY but it has contracted by 25% from the previous quarter
The return on equity has surged by 64% year-on-year but it has declined by 4.5% since the previous quarter
The return on assets has surged by 62% year-on-year but it has declined by 4.3% since the previous quarter

Dividends

What is HBIO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for HBIO.

Financial health

How did Harvard Bioscience financials performed over time
The total assets is 114% more than the total liabilities
HBIO's current ratio is down by 16% year-on-year and by 11% since the previous quarter
HBIO's quick ratio is down by 15% YoY and by 8% QoQ
Harvard Bioscience's debt is 41% less than its equity
The company's debt to equity fell by 21% YoY and by 3.3% QoQ
Harvard Bioscience's debt has decreased by 21% YoY and by 6% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.